NICE issues final guidance on vinflunine for advanced or metastatic transitional cell carcinoma of the urothelial tract (TA 272)

Source: NICE Area: Evidence > Drug Specific Reviews NICE has issued final guidance which does not support the use of vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract that has progressed after treatment with platinum-based chemotherapy (TA 272).   The Committee noted that vinflunine does not provide enough benefit to patients to justify its high cost, and did not qualify for special consideration.   See links below for further details.
Source: NeLM - Drug Specific Reviews - Category: Drugs & Pharmacology Source Type: news